|Articles|October 1, 2010

BioPharm International

  • BioPharm International-10-01-2010
  • Volume 23
  • Issue 10

BioPharm International, October 2010 Issue (PDF)

Biopharmaceutical Approvals in the US and EU: A Review
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 15 years ago

Uncertain Outlook for Biopharma Venture Capital

over 15 years ago

Regulatory Challenges Impede the Adoption of New Downstream Processing Technologies

over 15 years ago

Biopharmacetiucal Approval Trends in 2009

over 15 years ago

A Quality Culture Can Be the Industry's Core Strength

over 15 years ago

Biotech Companies Gain Support for Vaccine, Countermeasure Production

over 15 years ago

Taking on the Challenges

over 15 years ago

Biotech Cools Off as Capital Markets Weaken

over 15 years ago

The Role of Noncritical Process Parameters in Quality by Design

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!